Prof. Dr. med. Andreas Ramming



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Type 2 Innate Lymphoid Cells - Cellular Source of Profibrotic Mediators Rapidly and Persistently Recruited in Experimental Fibrosis and Systemic Sclerosis (2016) Weber S, Wohlfahrt T, Rauber S, Luber M, Englbrecht M, Dees C, Beyer C, et al. Conference contribution Dipeptidyl-Peptidase-4 (DPP4) Positive Fibroblast Subpopulation Promotes Fibrosis and Are a Molecular Target for Treatment of Fibrosis (2016) Soare A, Rauber S, Wohlfahrt T, Dees C, Liang R, Zhang Y, Chen CW, et al. Conference contribution Activating Transcription Factor 3-a New Linkage Between Vasculopathy and Organ Fibrosis in Systemic Sclerosis (2016) Wohlfahrt T, Soare A, Mallano T, Gourlaouen M, Moss S, Maurer B, Distler O, et al. Conference contribution Corrigendum: Evidence of innate lymphoid cell redundancy in humans (2016) Vely F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Ebbo M, Perchet T, et al. Journal article, Erratum Evidence of innate lymphoid cell redundancy in humans (2016) Vely F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Perchet T, Petit M, et al. Journal article Activating transcription factor 3 regulates canonical TGF? signalling in systemic sclerosis (2016) Mallano T, Palumbo-Zerr K, Zerr P, Zeller B, Beyer C, Dees C, Huang J, et al. Journal article Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis (2016) Wohlfahrt T, Usherenko S, Englbrecht M, Dees C, Weber S, Beyer C, Gelse K, et al. Journal article, Original article The transcription factor GLI2 as a downstream mediator of transforming growth factor-?-induced fibroblast activation in SSc (2016) Liang R, Sumova B, Cordazzo C, Mallano T, Zhang Y, Wohlfahrt T, Dees C, et al. Journal article Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis (2015) Huang J, Beyer C, Palumbo-Zerr K, Zhang Y, Distler A, Gelse K, Distler O, et al. Journal article From pathogenesis to therapy - Perspective on treatment strategies in fibrotic diseases (2015) Dees C, Distler J, Ramming A Journal article